Production (Stage)
TELA Bio, Inc.
TELA
$2.00
-$0.07-3.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.55% | 3.83% | 25.94% | 11.02% | 39.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.55% | 3.83% | 25.94% | 11.02% | 39.42% |
| Cost of Revenue | 14.33% | 19.97% | 31.44% | 17.27% | 32.07% |
| Gross Profit | 10.29% | -3.44% | 23.55% | 8.47% | 43.01% |
| SG&A Expenses | -4.24% | -17.30% | 10.73% | 12.58% | 24.85% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.06% | -11.18% | 12.24% | 11.29% | 25.24% |
| Operating Income | 15.59% | 31.96% | 8.01% | -11.66% | -10.24% |
| Income Before Tax | -98.06% | 27.45% | 5.34% | -16.77% | 52.93% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -98.98% | 28.56% | 5.34% | -16.77% | 52.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -98.98% | 28.56% | 5.34% | -16.77% | 52.93% |
| EBIT | 15.59% | 31.96% | 8.01% | -11.66% | -10.24% |
| EBITDA | 16.16% | 33.25% | 8.64% | -11.56% | -10.26% |
| EPS Basic | -8.03% | 56.34% | 6.17% | -10.04% | 63.26% |
| Normalized Basic EPS | 54.02% | 55.65% | 6.19% | -10.03% | 14.06% |
| EPS Diluted | -8.03% | 56.34% | 6.17% | -10.04% | 63.44% |
| Normalized Diluted EPS | 54.02% | 55.65% | 6.19% | -10.03% | 14.06% |
| Average Basic Shares Outstanding | 84.17% | 63.64% | 0.90% | 6.13% | 28.11% |
| Average Diluted Shares Outstanding | 84.17% | 63.64% | 0.90% | 6.13% | 28.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |